BPGbio is a leading biology-first AI-powered clinical stage biopharma focused on mitochondrial biology and protein homeostasis. The company has a deep pipeline of AI-developed therapeutics spanning oncology, rare disease and neurology, including several in late-stage clinical trials. BPGbio’s novel approach is underpinned by NAi, its proprietary Interrogative Biology Platform, protected by over 400 US and international patents; one of the world’s largest clinically annotated non-governmental biobanks with longitudinal samples; and exclusive access to the most powerful supercomputer in the world. With these tools, BPGbio is redefining how patient biology can be modeled using bespoke Bayesian AI specifically designed for solving large-scale biology challenges. Headquartered in greater Boston, the company is at the forefront of a new era in medicine, combining biology, multi-modal data, and AI to transform the way we understand, diagnose, and treat disease.
Company Details
- Employees
- 78
- Founded
- -
- Address
- 300 3rd Ave, Waltham,massachusetts 02451,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.BPGbio.com
- Keywords
- Biotechnology, AI drug discovery platform, rare diseases, Oncology, Neurology, AIDrugdiscovery, mitochondrial, protein homeostasis.
- HQ
- Waltham, Massachusetts
Bpgbio, Inc. Questions
Bpgbio, Inc.'s website is http://www.BPGbio.com
Bpgbio, Inc.'s LinkedIn profile is https://www.linkedin.com/company/bpgbio
Bpgbio, Inc. has
78 employees.
View email and phone details for 78
employees at Bpgbio, Inc..
Bpgbio, Inc.'s industry is
Biotechnology Research
Bpgbio, Inc.'s top competitors are
Anima Biotech,
Generate:biomedicines,
Insilico Medicine,
Cradle,
Insitro,
Iktos,
Recursion,
Atomwise,
Relay Therapeutics,
Alnylam Pharmaceuticals.
Bpgbio, Inc.'s categories are Biotechnology Research
Bpgbio, Inc.'s founding year is 2006
